|
|
Other links at Articles > Business of Medicine |
| 1. |
Report Seeks One-Stop Source for U.S. Health Info
|
|
|
For patients weary of scary headlines about popular treatments like the heart drug Vytorin, a new report issued on Thursday by the U.S. Institute of Medicine may offer welcome relief. Reuters Health Information
|
| 4. |
Heart-Imaging Agent Gets FDA Approval
|
|
|
Drug makers CV Therapeutics and Astellas Pharma Inc said on Friday the U.S. Food and Drug Administration (FDA) had approved their heart-imaging agent regadenoson, also called Lexiscan. Reuters Health Information
|
| 5. |
Poor and Medicaid Recipients With MI Have Longest Prehospital Delays
|
|
|
New research shows that those with Medicaid insurance and those living in low-income neighborhoods are less likely than their better-off counterparts to get to the hospital quickly after an acute MI. This adds to prior studies that have shown that race, sex, age, and comorbid conditions can influence the time taken to get to the hospital following AMI. Heartwire
|
|
|
